The observed DDR deficiency in TRIM33 knockdown MM cells, along with previous reports of enhanced sensitivity to DNA damaging agents in the absence of TRIM33, led us to investigate therapeutic vulnerabilities in our cell line models. Here, TRIM33 is linked to Miyoshi myopathy.